CX-2005

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameCX-2005
Drug Alias NameCX-2005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransferrin receptor protein 1 antagonists
TargetsTransferrin receptor protein 1
Therapy Area/IndicationsSolid tumoursLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCytomx Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCytomx Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A